Priscilla Chan discusses AI at the New York Academy of Sciences

aAdvances in artificial intelligence open the door to a host of new discoveries that could help scientists cure, prevent or manage all diseases by the end of this century. Dr. Priscilla Chan, co-founder and co-CEO of the Chan Zuckerberg Initiative (CZI), shared her perspective on how AI helps answer the most fundamental questions about human biology at a recent event with the New York Academy of Science.

Moderated by Rockefeller University President Dr. Richard Lifton, MD, PhD, the conversation highlighted CZI’s vision to build virtual cell models that scientists can use to make predictions about the behavior of healthy and diseased cells, which have broad applications will have for biomedical applications. research, disease diagnosis and therapeutic development. Dr. Chan also discussed the exciting advances coming from the CZ Biohub Network, including CZ Biohub New York’s vision to harness our immune system to detect, prevent and ultimately treat diseases before they progress.

As a technology-driven philanthropy, CZI is committed to building open source tools that accelerate the pace of research and enable AI at scale to push the boundaries of science. Read more about our vision to build virtual cell models.

###

About the Chan Zuckerberg Initiative
The Chan Zuckerberg Initiative was founded in 2015 to help solve some of society’s toughest challenges – from eradicating disease and improving education to addressing the needs of our communities. Through collaboration, providing resources, and building technology, our mission is to help build a more inclusive, equitable, and healthy future for all. For more information, please visit chanzuckerberg.com.